An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus

1. Mayhall CG. Prevention and control of vancomycin resistance in Gram-positive coccal microorganism: fire prevention and fire fighting. Infect Control Hosp Epidemiol. 1996; 17:353-5.10.2307/30141132Search in Google Scholar

2. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350:1670-3.10.1016/S0140-6736(97)07324-8Search in Google Scholar

3. Centers for Disease Control and Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan 1996. Morbl Mortal Wkly Rep. 1997. 46:624-6.Search in Google Scholar

4. Rybak MJ, Chin JN, Lau K, Sader KH, Jones RN. Increasing prevalence of glycopeptide heteroresistant S. sureus from the Detroit metropolitan area over a 20-year period (1986-2006). Abstract 17th Eur Congr Clin Microbiol Infect Dis (ECCMID), 2007; 032.10.1016/S0924-8579(07)70031-6Search in Google Scholar

5. Ploy MC, Grelaud C, Martin CC, de Lumley L, Dennis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet. 1998. 351:1212.10.1016/S0140-6736(05)79166-2Search in Google Scholar

6. Wong SS, Ho PL, Woo PC, Yuen KY. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis. 1999; 29:760-7.10.1086/52042910589883Open DOISearch in Google Scholar

7. Trakulsomboon S. Danchaivijitr S, Rongrungruang Y, Dhiraputra C, Susaemgrat W, Ito T, et al. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol. 1999; 39:591-5.10.1128/JCM.39.2.591-595.20018778111158112Search in Google Scholar

8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteen informational supplement. Approved standard M100-S16. Clinical and Laboratory Standards Institute, Wayne, USA. 2006.Search in Google Scholar

9. Howe RA, Noel AR, Bowker KE. 2003. The prevalence of heterogeneously vancomycin intermediate Staphylococcus aureus (hVISA) in the USA. Abstract 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2003; abstr. C2-1828.Search in Google Scholar

10. Delgado AJ, Riordan T, Lamichhane-Khadka R, Winnett DC, Jimenez J, Robinson K, et al. Heterovancomycin- intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico. J Clin Microbiol. 2007; 45: 1325-9. 10.1128/JCM.02437-06186582917267639Search in Google Scholar

11. Goldstein F. The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother. 2007; 59:1-4.10.1093/jac/dkl42917068009Search in Google Scholar

12. Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2007; 30:398-408.10.1016/j.ijantimicag.2007.07.01117888634Search in Google Scholar

13. Walsh TR, Bolmström A, Qwärnström A, Ho P, Wootton M, Howe RA, et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol. 2001; 39:2439-2444.10.1128/JCM.39.7.2439-2444.20018816711427551Search in Google Scholar

14. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Villanova, USA.Search in Google Scholar

15. Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, et al. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains. J Microbiol Methods. 2004; 57:231-9.10.1016/j.mimet.2004.01.01215063063Open DOISearch in Google Scholar

16. Wootton M, MacGowan AP, Walsh TR, Howe RA. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol. 2007; 45:329-32.10.1128/JCM.01508-06182900617108069Open DOISearch in Google Scholar

17. Lulitanond A, Chanawong A, Sribenjalux P, Kaewkes W, Vorachit M, Chongtrakool P, et al. Detection of heterogeneous, intermediate-vancomycin-resistant Staphylococcus aureus (hVISA) using lowconcentration vancomycin disks. Southeast Asian J Trop Med Public Health. 2006; 37:761-7.Search in Google Scholar